Hàn Quốc: Số người nhiễm COVID-19 lên 1.766, đã có 13 ca tử vong

Yonhap đưa tin, ngày 27/2, Hàn Quốc ghi nhận thêm 171 ca nhiễm mới dịch bệnh viêm đường hô hấp cấp COVID-19 do virus corona chủng mới ( SARS-CoV-2 ), nâng tổng số ca nhiễm bệnh lên thành 1.766 người.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh